Research Article

Methicillin Resistance and Staphylococcus aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results

Volume: 5 Number: 1 April 1, 2022

Methicillin Resistance and Staphylococcus aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results

Abstract

Background: The COVID-19 pandemic remains a serious problem adversely affecting public health. The present study has been conducted in an attempt to evaluate the nasal carriage of Staphylococcus aureus before and during the pandemic. Methods: In this study, the results of nasal cultures taken from patients who applied to our hospital for screening before and during the pandemic were retrospectively analyzed. Results: In total, 2707 patients participated in the study. Out of these patients, 1602 were admitted to our hospital in 2019 and 1105 in 2020. According to the results of the study, the detection rates of Staphylococcus aureus were found to be 5.1% and 0.8% in 2019 and 2020, respectively. Such a decrease occurring during the time of the Covid-19 pandemic period was found to be statistically significant (χ2 = 36.61; P = .000). On the other hand, an increase was detected in the rate of methicillin-resistant Staphylococcus aureus during the pandemic. It was determined to be 17.3% in 2019 whereas it was 55.6% in 2020. This was found to be statistically significant (χ2 = 7.12; P = .008). Conclusions: According to this study, there was a sharp decrease in Staphylococcus aureus carriage during the pandemic period compared to pre-pandemic, while methicillin-resistant Staphylococcus aureus rates increased more than 3 folds. This increase in methicillin-resistant Staphylococcus aureus rates may be due to the increasing trend of methicillin-resistant Staphylococcus aureus in recent years or may indicate that it depends on the measures associated with the pandemic. Further research in this area is essential.

Keywords

References

  1. Mahmoudi H. Bacterial co-infections and antibiotic resistance in patientswith COVID-19. GMS Hyg Infect Control. 2020;15: ISSN 2196-5226.
  2. Tang YW, Stratton CW. Staphylococcus aureus: an old pathogen with new weapons. Clin Lab Med. 2010;30(1):179-208.
  3. Sollid JUE, Furberg AS, Hanssen AM, Johannessen M. Staphylococcus aureus: determinants of human carriage. Infect Genet Evol. 2014;21:531-541.
  4. Kluytmans-Vandenbergh MFQ, Kluytmans JAJW. Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect. 2006;12(suppl 1):9-15.
  5. Emre A, Seyman D, Türker M, et al. Cases with skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Klimik Dergisi. 2020;33(2):180-184.
  6. Von Eıff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344(1):11-16.
  7. Alim A, Artan MO, Ataş M, Kalkan H, Madak S. Nasal carriage rate of staphylococcus auresus in individuals participating in the routine carrier inspection process in Sivas. Flora. 2012;17(4):202-205.
  8. Farrell JM, Zhao CY, Tarquinio KM, Brown SP. Causes and consequences of COVID-19 associated bacterial infections. Front Microbiol. 2021;12:(1-6).

Details

Primary Language

English

Subjects

Otorhinolaryngology

Journal Section

Research Article

Publication Date

April 1, 2022

Submission Date

January 13, 2022

Acceptance Date

March 17, 2022

Published in Issue

Year 2022 Volume: 5 Number: 1

APA
Altıntaş, M., Kar, M., Aydın Tığlı, G., & Çekin, Y. (2022). Methicillin Resistance and Staphylococcus aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results. European Journal of Rhinology and Allergy, 5(1), 20-23. https://doi.org/10.5152/ejra.2022.22056
AMA
1.Altıntaş M, Kar M, Aydın Tığlı G, Çekin Y. Methicillin Resistance and Staphylococcus aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results. Eur J Rhinol Allergy. 2022;5(1):20-23. doi:10.5152/ejra.2022.22056
Chicago
Altıntaş, Mustafa, Murat Kar, Gül Aydın Tığlı, and Yeşim Çekin. 2022. “Methicillin Resistance and Staphylococcus Aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results”. European Journal of Rhinology and Allergy 5 (1): 20-23. https://doi.org/10.5152/ejra.2022.22056.
EndNote
Altıntaş M, Kar M, Aydın Tığlı G, Çekin Y (April 1, 2022) Methicillin Resistance and Staphylococcus aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results. European Journal of Rhinology and Allergy 5 1 20–23.
IEEE
[1]M. Altıntaş, M. Kar, G. Aydın Tığlı, and Y. Çekin, “Methicillin Resistance and Staphylococcus aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results”, Eur J Rhinol Allergy, vol. 5, no. 1, pp. 20–23, Apr. 2022, doi: 10.5152/ejra.2022.22056.
ISNAD
Altıntaş, Mustafa - Kar, Murat - Aydın Tığlı, Gül - Çekin, Yeşim. “Methicillin Resistance and Staphylococcus Aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results”. European Journal of Rhinology and Allergy 5/1 (April 1, 2022): 20-23. https://doi.org/10.5152/ejra.2022.22056.
JAMA
1.Altıntaş M, Kar M, Aydın Tığlı G, Çekin Y. Methicillin Resistance and Staphylococcus aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results. Eur J Rhinol Allergy. 2022;5:20–23.
MLA
Altıntaş, Mustafa, et al. “Methicillin Resistance and Staphylococcus Aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results”. European Journal of Rhinology and Allergy, vol. 5, no. 1, Apr. 2022, pp. 20-23, doi:10.5152/ejra.2022.22056.
Vancouver
1.Mustafa Altıntaş, Murat Kar, Gül Aydın Tığlı, Yeşim Çekin. Methicillin Resistance and Staphylococcus aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results. Eur J Rhinol Allergy. 2022 Apr. 1;5(1):20-3. doi:10.5152/ejra.2022.22056

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.